* Degenerative valvular heart disease clearly diagnosed by ultrasound or clinical history with calcification manifestation (including no stenosis or insufficiency due to calcification, mild, moderate and severe stenosis and insufficiency caused by calcification).
Patients refuse to sign the informed consent form for the study.
* Non-degenerative valvular heart disease even if there is valvular calcification, such as rheumatic valvular heart disease, congenital valvular heart disease, etc.
* Valve lesions are evaluated by cardiac surgeons and have indications for surgical thoracotomy or interventional medical treatment and there are no surgical contraindications.
* Life expectancy less than 1 year. ⑤ Abnormal parathyroid function.
* Those with renal insufficiency who are planned to undergo dialysis treatment within half a year.
* Malignant tumor.
Clareo Health | Calcium-Phosphorus Regulation Therapy on Heart Valve Disease
